1. Home
  2. PRAX vs AVO Comparison

PRAX vs AVO Comparison

Compare PRAX & AVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • AVO
  • Stock Information
  • Founded
  • PRAX 2015
  • AVO 1983
  • Country
  • PRAX United States
  • AVO United States
  • Employees
  • PRAX N/A
  • AVO N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • AVO Farming/Seeds/Milling
  • Sector
  • PRAX Health Care
  • AVO Consumer Staples
  • Exchange
  • PRAX Nasdaq
  • AVO Nasdaq
  • Market Cap
  • PRAX 950.8M
  • AVO 836.8M
  • IPO Year
  • PRAX 2020
  • AVO 2020
  • Fundamental
  • Price
  • PRAX $59.22
  • AVO $12.05
  • Analyst Decision
  • PRAX Strong Buy
  • AVO Strong Buy
  • Analyst Count
  • PRAX 10
  • AVO 2
  • Target Price
  • PRAX $101.00
  • AVO $15.50
  • AVG Volume (30 Days)
  • PRAX 399.5K
  • AVO 282.6K
  • Earning Date
  • PRAX 08-12-2025
  • AVO 09-08-2025
  • Dividend Yield
  • PRAX N/A
  • AVO N/A
  • EPS Growth
  • PRAX N/A
  • AVO 108.17
  • EPS
  • PRAX N/A
  • AVO 0.52
  • Revenue
  • PRAX $8,122,000.00
  • AVO $1,392,900,000.00
  • Revenue This Year
  • PRAX N/A
  • AVO $8.85
  • Revenue Next Year
  • PRAX $4,434.72
  • AVO N/A
  • P/E Ratio
  • PRAX N/A
  • AVO $23.34
  • Revenue Growth
  • PRAX 270.02
  • AVO 29.50
  • 52 Week Low
  • PRAX $26.70
  • AVO $9.56
  • 52 Week High
  • PRAX $91.83
  • AVO $15.25
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 78.36
  • AVO 51.84
  • Support Level
  • PRAX $53.89
  • AVO $12.00
  • Resistance Level
  • PRAX $59.10
  • AVO $12.45
  • Average True Range (ATR)
  • PRAX 3.26
  • AVO 0.29
  • MACD
  • PRAX 0.59
  • AVO -0.03
  • Stochastic Oscillator
  • PRAX 88.19
  • AVO 38.93

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About AVO Mission Produce Inc.

Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.

Share on Social Networks: